Evidence map›Paper›PMID 34304572›Full record

ArticleEnvironmental science & technology2021

Revealing Adverse Outcome Pathways from Public High-Throughput Screening Data to Evaluate New Toxicants by a Knowledge-Based Deep Neural Network Approach.

Heather L Ciallella, Daniel P Russo, Lauren M Aleksunes, Fabian A Grimm, Hao Zhu

Open access · greenAbstract read
In one paragraph

Article in Environmental science & technology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Integrating network analysis and machine learning to elucidate chemical-induced pancreatic toxicity in zebrafish embryos.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  7. Review
  8. Advancing Toxicity Predictions: A Review onEnvironment & health (Washington, D.C.) · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling.Toxicological sciences : an official journal of the Society of Toxicology · 2023
    Article
  13. Article
  14. Machine Learning and Artificial Intelligence in Toxicological Sciences.Toxicological sciences : an official journal of the Society of Toxicology · 2022
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Heather L CiallellaCenter for Computational and Integrative Biology, Rutgers University Camden, Camden, New Jersey 08103, United States.
Daniel P RussoCenter for Computational and Integrative Biology, Rutgers University Camden, Camden, New Jersey 08103, United States.
Lauren M AleksunesDepartment of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey 08854, United States.
Fabian A GrimmExxonMobil Biomedical Sciences, Inc., Annandale, New Jersey 08801, United States.
Hao ZhuCenter for Computational and Integrative Biology, Rutgers University Camden, Camden, New Jersey 08103, United States.ORCID 0000-0002-3559-6129
Rutgers, The State University of New Jersey · USExxonMobil (United States) · US

Funding

Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI PANOS G. GEORGOPOULOS · 1988 to 2026
$47.4M
New Jersey Alliance for Clinical Translational Science: NJ ACTSUL1TR003017 · NCATS · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI PANETTIERI, REYNOLD ALEXANDER · 2019 to 2023
$28.9M
Placental Responses to Environmental Chemicals - Diversity Supplement 2R01ES029275 · NIEHS · RUTGERS, THE STATE UNIV OF N.J. · PI ALEKSUNES, LAUREN M, BARRETT, EMILY S · 2018 to 2022
$3.2M
Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for HepatotoxicityR01ES031080 · NIEHS · TULANE UNIVERSITY OF LOUISIANA · PI ZHU, HAO · 2020 to 2024
$2.3M
Predictive Computational Acute Toxicity Modeling by Profiling Chemicals With PublR15ES023148 · NIEHS · RUTGERS THE STATE UNIV OF NJ CAMDEN · PI ZHU, HAO · 2013 to 2018
$941k
NCATS NIH HHS UL1 TR003017NIEHS NIH HHS P30 ES005022NIEHS NIH HHS R01 ES029275NIEHS NIH HHS R01 ES031080NIEHS NIH HHS R15 ES023148
6 · The paper itself

Abstract

Traditional experimental testing to identify endocrine disruptors that enhance estrogenic signaling relies on expensive and labor-intensive experiments. We sought to design a knowledge-based deep neural network (k-DNN) approach to reveal and organize public high-throughput screening data for compounds with nuclear estrogen receptor α and β (ERα and ERβ) binding potentials. The target activity was rodent uterotrophic bioactivity driven by ERα/ERβ activations. After training, the resultant network successfully inferred critical relationships among ERα/ERβ target bioassays, shown as weights of 6521 edges between 1071 neurons. The resultant network uses an adverse outcome pathway (AOP) framework to mimic the signaling pathway initiated by ERα and identify compounds that mimic endogenous estrogens (i.e., estrogen mimetics). The k-DNN can predict estrogen mimetics by activating neurons representing several events in the ERα/ERβ signaling pathway. Therefore, this virtual pathway model, starting from a compound's chemistry initiating ERα activation and ending with rodent uterotrophic bioactivity, can efficiently and accurately prioritize new estrogen mimetics (AUC = 0.864-0.927). This k-DNN method is a potential universal computational toxicology strategy to utilize public high-throughput screening data to characterize hazards and prioritize potentially toxic compounds.

Indexed as

Adverse Outcome PathwaysEstrogen Receptor betaEstrogen Receptor alphaEstrogensHigh-Throughput Screening AssaysNeural Networks, ComputerEstrogen Receptor alphaEstrogen Receptor betaEstrogensadverse outcome pathwayartificial intelligencedeep learningestrogen receptorhigh-throughput screening datauterotrophic activity

Identifiers

PMID34304572
PMCPMC8713073
OpenAlexW3186265534

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.